HOT SESSION: IMMUNE RELATED ADVERSE EVENTS FROM CHECKPOINT INHIBITOR THERAPY

被引：1
|
作者：
Calabrese, L. [1 ]
机构：
[1] Cleveland Clin, Rheumatol, Cleveland, OH 44106 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.7762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP0098
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [41] Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy
    La-Beck, Ninh M.
    Owoso, Jesuwapelumi
    [J]. ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2024, 11 (09)
  • [42] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    [J]. THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [43] Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy
    Brumbaugh, Aaron D.
    Narurkar, Roshni
    Parikh, Kaushal
    Fanucchi, Michael
    Frishman, William H.
    [J]. CARDIOLOGY IN REVIEW, 2019, 27 (02) : 97 - 107
  • [44] Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
    Liu, Jie
    Yu, Jinming
    Meng, Xue
    [J]. JAMA ONCOLOGY, 2020, 6 (11) : 1813 - +
  • [45] Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment
    Muir, Christopher A.
    Clifton-Bligh, Roderick J.
    Long, Georgina, V
    Scolyer, Richard A.
    Lo, Serigne N.
    Carlino, Matteo S.
    Tsang, Venessa H. M.
    Menzies, Alexander M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : E3704 - E3713
  • [46] Immune-Related Adverse Events From Immune Checkpoint Inhibitors
    Marrone, K. A.
    Ying, W.
    Naidoo, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) : 242 - 251
  • [47] Setting the scene - a future 'epidemic' of immune-related adverse events in association with checkpoint inhibitor therapy
    Bermudez, Maria V.
    Papa, Sophie
    [J]. RHEUMATOLOGY, 2019, 58 : 1 - 6
  • [48] Insights from Pharmacovigilance: Gastrointestinal-Related Immune Checkpoint Inhibitor Adverse Events COMMENT
    Reese, Stephen W.
    Marchese, Maya
    McNabb-Baltar, Julia
    [J]. GASTROENTEROLOGY, 2020, 159 (04) : 1195 - +
  • [49] Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy
    Ekinci, Ferhat
    Balcik, Onur Yazdan
    Demir, Bilgin
    Gursoy, Pinar
    Ozveren, Ahmet
    Erdogan, Atike Pinar
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (08): : 996 - 1003
  • [50] Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events
    Kadowaki, Hiroshi
    Akazawa, Hiroshi
    Ishida, Junichi
    Komuro, Issei
    [J]. JMA JOURNAL, 2021, 4 (02): : 91 - 98
12345